Monday, August 12, 2013

Rocky Mountain Life Science Investor and Partnering Conference Announces Thirty Regional Companies for 2013 Presentation Lineup

Denver, CO, August 12, 2013 – Thirty companies from Arizona, Colorado, Montana and Utah have been chosen to present at the 2013 Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC), September 18-19, at The Ritz-Carlton in Denver, Colorado. The announcement is made by April Giles, President & CEO of the Colorado BioScience Association (CBSA), on behalf of the RMLIPC Selection Committee, who says the presenting companies were selected from more than 60 applicants by a committee of investors and industry experts. 

2013 Rocky Mountain Life Science Investor and Partnering Conference Presenting Companies:

AmideBio, LLC - Boulder, CO -
Biodesix - Boulder, CO -
BioFusionary - Wheat Ridge, CO -
Boulder Diagnostics - Boulder, CO -
Convoy Therapeutics - Oro Valley, AZ -
DiscGenics - Salt Lake City, UT -
EndoShape - Boulder, CO -
ENDURX Pharmaceuticals, Inc. - Oro Valley, AZ -
FitBionic - Boulder, CO -
Lazarus Medical Technologies - Salt Lake City, UT -
Lineagen - Salt Lake City, UT -
MBio Diagnostics - Boulder, CO -
MSDx - Tucson, AZ -
Nasseo, Inc. - Peoria, AZ -
Neuro Assessment Systems - Littleton, CO -
Prima-Temp, Inc. - Boulder, CO -
Regenesis Biomedical - Scottsdale, AZ -
Renaptys Vaccines, LLC - Aurora, CO -
Rocky Mountain Biologicals - Missoula, MT -
Sharklet Technologies, Inc. - Aurora, CO -
Sinopsys Surgical - Boulder, CO  -
Surefire Medical - Westminster, CO -
SuviCa - Boulder, CO -
Transverse Medical - Evergreen, CO -
Ventria Bioscience - Fort Collins, CO -
VetDC Inc. - Fort Collins, CO -
Vivaldi Biosciences - Fort Collins, CO -
Wasatch - Salt Lake City, UT -
Xalud Therapeutics, Inc. Boulder, CO -
Xenograft Corporation - Missoula, MT -

The 2013 Rocky Mountain Life Science Investor and Partnering Conference – spearheaded by the Colorado BioScience Association in collaboration with associations in Arizona, Montana, New Mexico and Utah — will open with a reception at the Colorado Governor’s Mansion September 18th and follow with a full day of company pitch presentations September 19th. The keynote breakfast will include Kyle Lefkoff, founder and General Partner of Boulder Ventures, leading a conversation with the CEOs of Colorado's two premier publicly-traded pharmaceutical companies-Patrick Mahaffy, Founder and CEO of Clovis Oncology and Ron Squarer, CEO of Array BioPharma. The keynote lunch will be a presentation from Johnson and Johnson Development Corporation executive leadership. For more information and registration details, visit

On Twitter, please use the hashtag #RockyMtnBioInvest for your tweets.

Link to the PitchEngine social media release

No comments:

Post a Comment